Showing results (1-10 of 34) with videos related to
Sort By:
Pageof 4
Therapeutische Umschau. Revue Therapeutique|July 10, 2003
[Hallucinogens, amphetamines and entactogens]F X Vollenweider, M F Vollenweider-ScherpenhuyzenNeuroreport|January 6, 1999
Psilocybin induces schizophrenia-like psychosis in humans via a serotonin-2 agonist actionF X Vollenweider, M F Vollenweider-Scherpenhuyzen, A Bäbler, et al.Pharmacopsychiatry|October 1, 1998
Advances and pathophysiological models of hallucinogenic drug actions in humans: a preamble to schizophrenia researchF X VollenweiderDialogues in Clinical Neuroscience|October 29, 2011
Brain mechanisms of hallucinogens and entactogensF X VollenweiderBrain Research Bulletin|December 26, 2001
A systems model of altered consciousness: integrating natural and drug-induced psychosesF X Vollenweider, M A GeyerEuropean Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|June 29, 2000
Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humansM E Liechti, F X VollenweiderJournal of Psychopharmacology (Oxford, England)|December 6, 2000
The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteersM E Liechti, F X VollenweiderPsychopharmacology|April 21, 2001
Gender differences in the subjective effects of MDMAM E Liechti, A Gamma, F X VollenweiderJournal of Neurochemistry|May 1, 1990
Effect of climbing fiber deprivation on release of endogenous aspartate, glutamate, and homocysteate in slices of rat cerebellar hemispheres and vermisF X Vollenweider, M Cuénod, K Q DoNeuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|August 27, 1998
Psychological and cardiovascular effects and short-term sequelae of MDMA ("ecstasy") in MDMA-naïve healthy volunteersF X Vollenweider, A Gamma, M Liechti, et al.Pageof 4